{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"volume":["18(1)"],"submitter":["Tripon F"],"pubmed_abstract":["<h4>Introduction</h4>the aim of the study was to investigate the contribution of TERT rs2736100 and rs2853669 gene polymorphisms in defining the genetic predisposition to acute myeloid leukaemia (AML), their association with different prognostic markers, and their impact on survival, outcome, and the prognosis of affected patients. Also, we investigated the association of TERT SNPs in AML in the presence or absence of DNMT3A (R882), NPM1, and FLT3 mutations.<h4>Material and methods</h4>A total of 509 participants were enrolled in our study, consisting of 146 AML patients and 363 healthy participants, with no history of malignancy. TERT rs2736100 and rs2853669 polymorphisms were genotyped by using TaqMan SNP genotyping assay FLT3 (ITD, D835), DNMT3A (R882), and NPM1 c.863_864insTCTG (type A"],"journal":["Archives of medical science : AMS"],"pagination":["103-111"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC8826982"],"repository":["biostudies-literature"],"pubmed_title":["TERT rs2853669 as a predictor for overall survival in patients with acute myeloid leukaemia."],"pmcid":["PMC8826982"],"pubmed_authors":["Banescu C","Crauciuc AG","Trifa AP","Demian S","Duicu C","Boglis A","Benedek I","Moldovan VG","Iancu M","Tripon F"],"additional_accession":[]},"is_claimable":false,"name":"TERT rs2853669 as a predictor for overall survival in patients with acute myeloid leukaemia.","description":"<h4>Introduction</h4>the aim of the study was to investigate the contribution of TERT rs2736100 and rs2853669 gene polymorphisms in defining the genetic predisposition to acute myeloid leukaemia (AML), their association with different prognostic markers, and their impact on survival, outcome, and the prognosis of affected patients. Also, we investigated the association of TERT SNPs in AML in the presence or absence of DNMT3A (R882), NPM1, and FLT3 mutations.<h4>Material and methods</h4>A total of 509 participants were enrolled in our study, consisting of 146 AML patients and 363 healthy participants, with no history of malignancy. TERT rs2736100 and rs2853669 polymorphisms were genotyped by using TaqMan SNP genotyping assay FLT3 (ITD, D835), DNMT3A (R882), and NPM1 c.863_864insTCTG (type A","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022","modification":"2025-04-04T19:30:04.582Z","creation":"2025-04-04T19:30:04.582Z"},"accession":"S-EPMC8826982","cross_references":{"pubmed":["35154531"],"doi":["10.5114/aoms/100673"]}}